Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
NATU3 · B3 · Brazil · Farmacêutico e Higiene
In shortNatura Cosméticos S.A. is loss-making, burns cash and carries moderate debt, with revenue growing (+2.6% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 6.5% | 38/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -8.2% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -16.1% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 7.1% | 47/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.65× | 71/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.48× | 85/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 1.57× | 69/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 1.63× | 1/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 2.71 | 41/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -2.3% | 11/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 2 of 5 | 25/100 |
Weight in the score: 20%
| Profitable years (last 5) | 4 of 5 | 80/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 25.0% | 19/100 |
| Operating margin volatility | 2.7% | 84/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 2.6% | 31/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
1 older year available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
BRL millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 20,735 | 20,207 | 14,928 | 21,272 | 21,823 |
| Cost of revenue | 5,564 | 5,931 | 5,038 | 7,063 | 7,287 |
| Gross profit | 15,171 | 14,276 | 9,890 | 14,208 | 14,536 |
| Selling, general & admin | 12,511 | 12,161 | 7,421 | 11,146 | 11,709 |
| Operating income | 2,103 | 1,584 | 1,980 | 1,596 | 1,416 |
| Interest expense | 3,791 | 5,677 | 2,113 | 546 | 867 |
| Pre-tax income | 1,365 | 90 | (133) | 1,050 | 549 |
| Income tax | 431 | 33 | 588 | 21 | 20 |
| Net income | 934 | 124 | 6,440 | 761 | (1,785) |
| Diluted EPS | BRL1.02 | BRL0.13 | BRL7.00 | BRL0.83 | −BRL0.88 |
1 older year available with the 10-year history. Essential plan, from €8.25/month →
2.71 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
1/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: CVM (dados.cvm.gov.br). Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Mar 16, 2026